Life Sciences

The listing venue of choice for European life science companies

With its liquid pan-European market, providing access to a truly global investor community and strong eco-system, Euronext is the preferred European stock exchange for life science companies.

The listing venue of choice in Europe

Euronext is the most dynamic marketplace in Europe and the listing venue of choice with 50% European market share in number of IPOs since 2010.

37 life science companies have listed since January 2010, raising €721 million to finance research and growth.  In total, Euronext hosts 63 life science companies on its markets, representing a combined market capitalisation of €12.7 billion.

Highly liquid market

Euronext listed companies are highly liquid with a yearly trading activity of €18 billion in 2014, equal to 140% of issuers’ market capitalisation.

Trading activity on Euronext life science SMEs has increased by 270% since 2012.

International investments represent 70%

Euronext is the European exchange that attracts the most diversified international pool of investors. 37% of the capital invested in Euronext life science companies originates from US investors and 32% from Euronext countries.

NextBiotech index: +38% in 2014

The NextBiotech index illustrates the performance of Euronext life science companies. It has shown a variation of +38% in 2014 and +88% since January 2012.